Neothetics

NEOT

Sector
Healthcare

Industry
Biotechnology

Website
lithera.com




Buy / Sell (dollars)

1 Month

96% 96% Complete (success)
4% 4% Complete (danger)
$10.000M
avg. $10.000M
$413,018.40
avg. $413,018.40

Buy/Sell Ratio

24.212

Transactions

6

Filers

10

3 Month

95.7% 95.7% Complete (success)
4.3% 4.3% Complete (danger)
$10.000M
avg. $3.333M
$446,524.90
avg. $148,841.63

Buy/Sell Ratio

22.395

Transactions

13

Filers

13

12 Month

86.7% 86.7% Complete (success)
13.3% 13.3% Complete (danger)
$11.396M
avg. $949,704.64
$1.744M
avg. $145,343.04

Buy/Sell Ratio

6.534

Transactions

31

Filers

13

24 Month

92.5% 92.5% Complete (success)
7.5% 7.5% Complete (danger)
$21.375M
avg. $890,632.35
$1.744M
avg. $72,671.52

Buy/Sell Ratio

12.256

Transactions

32

Filers

13

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers